The Semaglutide Report

Semaglutide before surgery

Tell the people doing the procedure that you take it. That is the instruction both labels give, and they are explicit that nobody yet knows whether pausing the drug or fasting longer would help.1,2

On this page

The warning, in the label's own words

WEGOVY and OZEMPIC carry this as a numbered warning, and the wording is the same on both except for the product name:

There have been rare postmarketing reports of pulmonary aspiration in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures requiring general anesthesia or deep sedation who had residual gastric contents despite reported adherence to preoperative fasting recommendations.

WEGOVY prescribing information, section 5.10. 1

Pulmonary aspiration means stomach contents going into the airway. The detail that makes this a warning rather than a footnote is in the last clause: these people had followed the fasting instructions. The ordinary safeguard did not do what it usually does, because the stomach had not emptied on the usual schedule.1,2

What the labels admit they cannot tell you

This is the sentence that most pages on this subject leave out, and it is the reason this one prints no rule:

Available data are insufficient to inform recommendations to mitigate the risk of pulmonary aspiration during general anesthesia or deep sedation in patients taking WEGOVY, including whether modifying preoperative fasting recommendations or temporarily discontinuing WEGOVY could reduce the incidence of retained gastric contents.

WEGOVY prescribing information, section 5.10. 1

So there is no labeled number of days to stop before a procedure, no labeled longer fast and no labeled dose to skip. If you have read an interval somewhere, it did not come from these documents. Anesthesia teams do publish their own guidance and it changes; yours is the one that applies to you, and telling them is what puts you in it.1,2

What to do with this before a procedure

The labels give one instruction and it is the same on both: instruct patients to inform their healthcare providers prior to any planned surgeries or procedures. In practice that means saying it to the surgeon, to the anesthesia team and to whoever books the appointment, because the person who plans your fasting may not be the person holding your medication list.1,2

Say which product and which dose, and when your last one was. The WEGOVY schedule and the OZEMPIC schedule are where those numbers are, and the missed-dose page covers what the labels say if a week gets skipped, which is a question that may come up afterwards. If restarting raises a tolerability question, the side-effect timing guide gives trial context to discuss with the prescriber.

Questions

Do I have to stop semaglutide before surgery?

The labels do not say to. They say the available data are insufficient to tell anyone whether temporarily discontinuing the drug or changing fasting instructions would reduce the risk of retained gastric contents. The decision belongs to the team doing the procedure, which is why the labels tell patients to inform them.1,2

Does this apply to a colonoscopy or a dental procedure?

The warning is written for elective surgeries or procedures requiring general anesthesia or deep sedation, which is a description of the sedation rather than of the operation. Whether yours is in that category is a question for the people performing it.1,2

How common is this?

The labels call the reports rare and postmarketing, which means they were sent in after approval rather than counted in a trial. No rate appears in either label, so no rate appears here.1,2

  • Dosing

    If you missed a dose

    The approved labels give different instructions. All of them, quoted in full.

  • Dosing

    WEGOVY doses

    Both ladders from the label's own tables, and why the top of the injection's depends on the approved use.

  • Side effects

    Acid reflux on semaglutide

    What the labels count, and why two 2026 studies of the same question disagree.

  • Side effects

    WEGOVY side effects

    What WEGOVY's own label reports, at what rate, against placebo, and how many people stopped.

Sources

  1. WEGOVY- semaglutide injection, solution; WEGOVY- semaglutide tablet

    DailyMed, U.S. National Library of Medicine. Updated June 18, 2026 — label Revised: 6/2026.

  2. OZEMPIC- semaglutide injection, solution

    DailyMed, U.S. National Library of Medicine. Updated June 1, 2026 — label Revised: 5/2026.

A reference, not medical advice, and not a substitute for your prescriber or pharmacist. If you think you are having a medical emergency, call your local emergency number.